Found: 178
Select item for more details and to access through your institution.
The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 16, p. 1745, doi. 10.3390/diagnostics14161745
- By:
- Publication type:
- Article
Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 7, p. 2365, doi. 10.1007/s00277-024-05615-0
- By:
- Publication type:
- Article
Major cardiovascular events in long-term multiple myeloma survivors: a Korean case–control study (the CAREMM-2105 study).
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01368-2
- By:
- Publication type:
- Article
The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR).
- Published in:
- BMC Medical Research Methodology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12874-024-02227-0
- By:
- Publication type:
- Article
Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52720-1
- By:
- Publication type:
- Article
Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 18, p. 16279, doi. 10.1007/s00432-023-05385-8
- By:
- Publication type:
- Article
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44241-0
- By:
- Publication type:
- Article
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44241-0
- By:
- Publication type:
- Article
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4783, doi. 10.3390/cancers15194783
- By:
- Publication type:
- Article
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e360, doi. 10.1016/j.clml.2023.06.011
- By:
- Publication type:
- Article
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 13, p. 11907, doi. 10.1007/s00432-023-04993-8
- By:
- Publication type:
- Article
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
- By:
- Publication type:
- Article
Correction: Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Generation of time-synchronized two-color X-ray free-electron laser pulses using phase shifters.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39322-z
- By:
- Publication type:
- Article
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
- By:
- Publication type:
- Article
Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 491, doi. 10.1016/j.clml.2023.03.007
- By:
- Publication type:
- Article
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00385-w
- By:
- Publication type:
- Article
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
- By:
- Publication type:
- Article
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 863, doi. 10.1007/s00277-023-05090-z
- By:
- Publication type:
- Article
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1666, doi. 10.3390/cancers15061666
- By:
- Publication type:
- Article
Cytogenetic and molecular characteristics and outcomes of adult patients with early T‐cell precursor acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 137, doi. 10.1111/ejh.13883
- By:
- Publication type:
- Article
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 2, p. 225, doi. 10.1007/s12185-022-03479-6
- By:
- Publication type:
- Article
Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 454, doi. 10.3390/cancers15020454
- By:
- Publication type:
- Article
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00797-8
- By:
- Publication type:
- Article
Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score–matched cohort analysis.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231154713
- By:
- Publication type:
- Article
Review of technical achievements in PAL-XFEL.
- Published in:
- AAPPS Bulletin, 2022, v. 32, n. 1, p. 1, doi. 10.1007/s43673-022-00045-4
- By:
- Publication type:
- Article
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00770-x
- By:
- Publication type:
- Article
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01374-5
- By:
- Publication type:
- Article
Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 4, p. 553, doi. 10.1007/s12185-022-03378-w
- By:
- Publication type:
- Article
Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184485
- By:
- Publication type:
- Article
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 465, doi. 10.1159/000521912
- By:
- Publication type:
- Article
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e751, doi. 10.1016/j.clml.2022.04.005
- By:
- Publication type:
- Article
Correction to: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133199
- By:
- Publication type:
- Article
Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805).
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 1, p. 110, doi. 10.1007/s12185-022-03332-w
- By:
- Publication type:
- Article
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1217, doi. 10.1007/s00277-022-04776-0
- By:
- Publication type:
- Article
Control Scheme of Phase-Shifter for Photon Energy Scan.
- Published in:
- Photonics, 2022, v. 9, n. 6, p. 418, doi. 10.3390/photonics9060418
- By:
- Publication type:
- Article
Recent Progress of the PAL-XFEL.
- Published in:
- Applied Sciences (2076-3417), 2022, v. 12, n. 3, p. 1010, doi. 10.3390/app12031010
- By:
- Publication type:
- Article
Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.797028
- By:
- Publication type:
- Article
Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 1, p. 135, doi. 10.1007/s12185-021-03231-6
- By:
- Publication type:
- Article
A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML).
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221081637
- By:
- Publication type:
- Article
Durable outcomes of double cord blood transplantation in adults with acute lymphoblastic leukemia: high-risk features for early and long-term mortality.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221076762
- By:
- Publication type:
- Article
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CT.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00577-2
- By:
- Publication type:
- Article
Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Low‐dose thymoglobulin for prevention of chronic graft‐versus‐host disease in transplantation from an HLA‐matched sibling donor.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 11, p. 1441, doi. 10.1002/ajh.26320
- By:
- Publication type:
- Article
Reactivation of Resolved Hepatitis B After Daratumumab for Multiple Myeloma.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 6, p. e1372, doi. 10.1093/cid/ciab302
- By:
- Publication type:
- Article
Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 9, p. 4969, doi. 10.1007/s00520-021-06017-y
- By:
- Publication type:
- Article
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1065, doi. 10.1007/s00277-021-04405-2
- By:
- Publication type:
- Article
Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial‐unfit patients and subsequent therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 101, doi. 10.1111/bjh.17071
- By:
- Publication type:
- Article
Prognosis Prediction in Initially Diagnosed Multiple Myeloma Patients Using Intravoxel Incoherent Motion‐Diffusion Weighted Imaging and Multiecho Dixon Imaging.
- Published in:
- Journal of Magnetic Resonance Imaging, 2021, v. 53, n. 2, p. 491, doi. 10.1002/jmri.27321
- By:
- Publication type:
- Article